查看完整行情页>>

|

货币单位:美元(USD)

赛诺菲-安万特

Sanofi (sny)

实时(?):
盘后(?):
读取中...
  • -- (--%)
开盘价:-- 最高价:-- 最低价:-- 52周最高价:-- 52周最低价:--
成交量:-- 平均成交量:-- 市值:-- 市盈率:-- 预期市盈率:--
每股收益:-- 贝塔系数:-- 股息:-- 收益率:-- 总股本:--
Serge Weinberg Serge Weinberg is a French businessperson who founded Institut du Cerveau et de la Moelle Épinière and Weinberg Capital Partners SAS and who has been at the head of 19 different companies. Mr. Weinberg is Chairman of Maremma SASU, Chairman for Financière Piasa SAS, Chairman for Piasa Holding SAS, Chairman of Sanofi, President at Weinberg Capital Partners SAS and Manager for Maremma. Serge Weinberg is also on the board of Piasa SA (former Chairman) and AFEPT and Manager for Alret and Member of Council on Foreign Relations, Inc. In the past Mr. Weinberg was Chairman-Supervisory Board at Tess SAS, Chairman & Chief Executive Officer at Rexel SA, Chairman of Accor SA, Chairman at CORUM Vermögensverwaltung AG, Chairman-Supervisory Board at Financière Tess SAS, Chairman-Supervisory Board at Financière Climater SAS, Director at VL Holding (France), Chief Executive Officer & Director at Pallas Finance, Chairman-Management Board at Kering SA, President-CFAO at Pinault SARL, Manager at Adoval, Chairman of Montres CORUM Sàrl, Chairman & Chief Executive Officer of Havas Tourisme, President of Compagnie Française de L'Afrique Occidentale SA and Deputy General Manager-Finance at France 3 SA. Serge Weinberg received a graduate degree from Institut d'Études Politiques d'Aix-en-Provence and an undergraduate degree from Ecole Nationale d'Administration.
Bernard Charlès Bernard Charlès is a French businessperson who has been at the helm of 15 different companies. Currently, he occupies the position of Vice Chairman & Chief Executive Officer at Dassault Systèmes SA and Chairman for Dassault Systemes Geovia, Inc., Chairman for Centric Software, Inc., Chairman & Chief Executive Officer of Exa Corp., Chairman at IQMS, Chairman at Dassault Systèmes Corp., Chairman at Dassault Systemes Simulia Corp. and Chief Executive Officer & Vice Chairman at Exalead SA (which are all subsidiaries of Dassault Systèmes SA) and Chairman of Dassault Systemes Solidworks Corp. He is also on the board of Sanofi and Member of National Academy of Engineering. In his past career Bernard Charlès was Chairman at Dassault Systèmes Canada Software, Inc., Chairman-Supervisory Board at Dassault Systemes 3DExcite GmbH, Chairman of Dassault Systemes Biovia Corp., Chairman at Dassault Systemes Enovia Corp., Chairman of Delmia Corp., President of Dassault Systèmes Canada, Inc. and Member of Académie des Technologies. He received an undergraduate degree from École normale supérieure de Cachan.
John C. Reed John C. Reed founded Idun Pharmaceuticals, Inc. and Apoptos, Inc. Currently, he occupies the position of EVP & Global Head-Research & Development at Sanofi and President & Director at Synthorx, Inc. (a subsidiary of Sanofi). He is also on the board of BIOCOM. He previously held the position of Head-Roche Pharma Research & Early Development at Roche Holding AG, President, Chief Executive Officer & Professor at Sanford Burnham Prebys Medical Discovery Institute, Associate Member at the University of California San Diego, Assistant Director at the University of Pennsylvania and Associate Member at Whitaker Institute of Biomedical Engineering. He received an undergraduate degree from the University of Virginia and a doctorate from Perelman School of Medicine.
Patrick Kron Founder of Pkc&I SAS, Patrick Kron is a French businessperson who has been at the head of 12 different companies and is Chairman at this company and Chairman of Imerys SA. Mr. Kron is also on the board of 6 other companies. In his past career he occupied the position of Chairman & Chief Executive Officer of Alstom SA Chairman & Chief Executive Officer at Alstom Transport SA, Chairman for ALSTOM Resources Management SAS, Chief Executive Officer & Director at Alstom Asia Pacific Sdn. Bhd. and Managing Director & Director at Alstom Asia Pte Ltd. (which are all subsidiaries of Alstom SA), Chairman for Mersen SA and Chairman & Chief Executive Officer at Carbone Lorraine Applications Electriques (a subsidiary of Mersen SA), Chief Executive Officer at Vivendi SA, Chairman & Chief Executive Officer of Pechiney Electrométallurgie SA, Chief Executive Officer at Imerys SA, Chief Operating Officer at American National Can Corp and Manager-Food & Health Care Packaging Sector at Pechiney SA. Patrick Kron received an undergraduate degree from Ecole Polytechnique and an undergraduate degree from École Nationale Supérieure des Mines de Paris.
Alan J. Main Presently, Alan J. Main is Executive Vice President-CMC & Supply Operations at Lexicon Pharmaceuticals, Inc. In the past Dr. Main held the position of President & Chief Executive Officer at Coelacanth Corp and Senior Vice President-US Research at Novartis Pharmaceuticals Corp. Dr. Main received an undergraduate degree from the University of Aberdeen and a doctorate from The University of Liverpool.
Muzammil M. Mansuri Presently, Muzammil M. Mansuri is Executive Chairman at Adaptive Therapeutics, Inc. He is also Executive VP-Strategy & Business Development at Sanofi. Dr. Mansuri previously was General Partner of Flagship Pioneering, SVP-Research & Development Strategy at Gilead Sciences, Inc. and Chairman & Chief Executive Officer at Gilead Connecticut, Inc. (a subsidiary of Gilead Sciences, Inc.), Director-Central Chemistry at Bristol-Myers Squibb Co., Senior Advisor at JSB-Partners LP, Chief Operating Officer & Executive Vice President for GPC Biotech, Inc., President & Chief Executive Officer at BIKAM Pharmaceuticals, Inc. and Research Scientist at Shell Research Ltd. He received a doctorate and an undergraduate degree from University College London, a doctorate from the University of California, Los Angeles and a doctorate from Columbia University.
Lise Kingo Lise Kingo occupies the position of Chairman for Danish Council On Corporate Social Responsibility. She is also on the board of Sanofi and Learning Disabilities Association of Minnesota and Chief Executive Officer & Executive Director at United Nations Global Compact and Professor at Vrije Universiteit Amsterdam. In her past career she occupied the position of Chairman of Steno Diabetes Center An and Chief of Staff & Executive Vice President at Novo Nordisk A. She received an undergraduate degree from the University of Aarhus, an undergraduate degree from Copenhagen Business School and a graduate degree from the University of Bath.
Carole Piwnica Ms. Carole Piwnica is Member-Supervisory Board at Rothschild & Co. SCA, Chairman at i2O Water Ltd., Independent Director at Sanofi, Independent Director at Eutelsat Communications SA, Independent Director at Amyris, Inc., a Director at Select Music & Video Distribution Ltd., a Managing Director at Naxos UK Ltd., a Managing Director at NAXOS Capital Managers SARL, a Member at New York State Bar Association and a Member at Paris Bar Association. She is on the Board of Directors at Rothschild & Co. SCA, Sanofi, Elevance Renewable Sciences, Inc., Eutelsat Communications SA, Amyris, Inc., Big Red, Inc., Select Music & Video Distribution Ltd. and RecyCoal Ltd. Ms. Piwnica was previously employed as Independent Director by Louis Delhaize SA, Independent Non-Executive Director by Aviva Plc, Non-Executive Director by SPADEL SA, a Director & Vice Chairman-Governmental Affairs by Tate & Lyle Plc, and Chairman by Amylum. She also served on the board at BioAmber, Inc., Confederation of the Food & Drink Industries of Eu, Alfred C. Toepfer International GmbH, Charal SAS, Cacao Barry, and TargeGen, Inc. Ms. Piwnica received her graduate degree from Université Libre de Bruxelles and a graduate degree from New York University.
Gilles Schnepp Gilles Schnepp is a French businessperson who has been at the head of 26 different companies. Presently, Mr. Schnepp occupies the position of Chairman at Legrand SA, Chairman at TCL Low Voltage Electrical (Wuxi) Co. Ltd., Chairman of Alpes Technologies SA, Chairman for Legrand (S) Pte Ltd., Chairman & Co-Chief Executive Officer at Legrand Electric Ltd., Chairman at S2S SAS, Chairman at Distrasa SA, Chairman at URA SAS, Chairman at Groupe Arnould SAS, Chairman of Sarlam, Chairman for Simapel, Chairman at BTICINO Philippines, Inc., Chairman of LEGRAND Magyarország Villamossági Rendszerek Zrt., Manager at Legrand SNC and Manager at Planet-Wattohm SNC (which are all subsidiaries of Legrand SA), Chairman for Tenby Electrical Accessories Ltd., Chairman at Compagnie Franco Européenne d'Electricité, Chairman of Préfatech, Chairman for Appareillage Electrique Chessy, Chairman at Pammelec SAS, Chairman at Fidelec, Chairman at Legrand China Holding and President of Fédération des Industries Electriques, Electroniques. He is also Manager of Legrand SNC and Manager at Planet-Wattohm SNC and on the board of 22 other companies. In the past he was Chairman for INTERVOX Systèmes SA, Chairman at BTicino SpA, Chairman-Supervisory Board at Chateaudun Développement III SAS, Chairman of ICM Group SA, Chairman & Chief Executive Officer of Legrand France SA, Director & Manager at Legrand SLV doo and Vice President of Merrill Lynch Finance SA. Mr. Schnepp received an undergraduate degree from École des Hautes Études Commerciales de Paris.
Melanie Georgina Lee Melanie Georgina Lee founded Think10 and NightstaRx Ltd. Dr. Lee is on the board of Sanofi and UK DRI Ltd. and Chief Executive Officer at Lifearc. Dr. Lee previously occupied the position of Chairman for Cancer Research Technology Ltd., Chief Executive Officer at NightstaRx Ltd., Executive Vice President-Research & Development at UCB Pharma, Inc., Director-Research & Development at Celltech Group Ltd., Chief Scientific Officer of BTG Plc, President-New Medicines at UCB Celltech, Principal at GlaxoSmithKline Pharmaceuticals SA (Belgium), Research Unit Head-Receptor Systems at GlaxoWellcome and Director at Think10. She received an undergraduate degree from York University and a doctorate from The National Institute For Medical Research.
Laurent Attal Currently, Laurent Attal occupies the position of Vice President & GM-Research & Innovation at L'Oréal SA. Dr. Attal is also on the board of Sanofi and L'Oréal Corporate Foundation. In the past Dr. Attal held the position of Chief Executive Officer of Vichy, President & Chief Executive Officer at L'Oréal USA, Inc. and Manager at Galderma SA. Dr. Attal received an MBA from INSEAD.
Claudie Haigneré Claudie Haigneré is Member of Academie de l'air et de l'espace, Member of Académie des Sciences et Technologies, Member of Académie Des Sciences D'Outre-Mer and Member of Academie des Sports and on the board of 6 other companies. In her past career she held the position of Chairman for Universcience.fr, Chairman at La Géode, Counselor at European Space Agency (France), Member of International Academy of Astronautics and Member of Académie des Technologies.
Emmanuel Andre Marie Babeau Emmanuel Andre Marie Babeau is Chief Financial Officer of Philip Morris International, Inc. He is also Managing Partner at Sci Getij and on the board of 12 other companies. He previously held the position of Deputy Chief Executive Officer-Finance & Legal at Schneider Electric SE Chairman & Member-Management Board at Schneider Electric Services International, Chief Financial Officer for Schneider Electric Ltd. and Member-Management Board at Schneider SA (which are all subsidiaries of Schneider Electric SE) and Deputy Chief Executive Officer of Pernod Ricard SA. Mr. Babeau received an undergraduate degree from ESCP Europe Campus Paris.
Rachel Duan Rachel Duan is on the board of AXA SA and Sanofi and Senior Vice President of General Electric Co. In the past she was President & Chief Executive Officer at GE Healthcare China and Commercial Director at GE Plastics China Ltd. She received an MBA from the University of Wisconsin and an undergraduate degree from Shanghai International Studies University.
Karen Linehan Presently, Karen Linehan holds the position of Executive VP-Legal Affairs & General Counsel at Sanofi. She received a graduate degree and an undergraduate degree from Georgetown University.
Philippe Luscan Philippe Luscan is Executive Vice President-Global Industrial Affairs at Sanofi. In the past he occupied the position of Production Manager at Danone SA. Mr. Luscan received an undergraduate degree from Ecole Polytechnique and an undergraduate degree from École Nationale Supérieure des Mines de Paris.
Olivier Antoine M. Charmeil Olivier Antoine M. Charmeil is EVP-General Medicines & Emerging Markets at Sanofi. In his past career Mr. Charmeil occupied the position of Chairman-Management Board at Zentiva Group AS, Chairman & Chief Executive Officer for Sanofi-Synthélabo SA and Head-Business Development of Sanofi Pharma. Mr. Charmeil received an undergraduate degree from Sciences Po and an undergraduate degree from École des Hautes Études Commerciales de Paris.
Fabienne Lecorvaisier Fabienne Lecorvaisier is Chief Financial Officer & Executive Vice President at Air Liquide SA and Chairman & Chief Executive Officer of Air Liquide Finance SA and Executive Vice President at Air Liquide International Corp. (both are subsidiaries of Air Liquide SA). Ms. Lecorvaisier is also Executive Vice President of Air Liquide International Corp. and on the board of 8 other companies. Fabienne Lecorvaisier previously occupied the position of Vice President-Operations & Finance at Air Liquide Italia SpA, Chief Financial Officer at Essilor Group Canada, Inc., Director-Finance & Information Systems at Essilor of America, Inc., Assistant General Manager at Taittinger SAS and Assistant General Manager at Banque du Louvre. Ms. Lecorvaisier received an undergraduate degree from Ecole Nationale des Ponts et Chaussées.
Thomas C. Südhof Founder of Reata Pharmaceuticals, Inc., Neucyte, Inc. and Circuit Therapeutics, Inc., Thomas C. Südhof is an entrepreneur is on the board of Sanofi and Abide Therapeutics, Inc. and Professor at Stanford University School of Medicine. In his past career he occupied the position of Assistant Professor at The University of Texas Southwestern Medical Center. He received a doctorate from RWTH Aachen University and an undergraduate degree from the University of Gottingen.
Jean-Baptiste Chasseloup de Chatillon Jean-Baptiste Chasseloup de Chatillon is a French businessperson who has been the head of 5 different companies and occupies the position of Chief Financial Officer & Executive Vice President for Sanofi, Chairman of Mister-Auto SAS and Vice Chairman & Chief Executive Officer of PSA International SA. He is also Chief Financial & Information Officer at Fondation PSA Peugeot Citroën, Member of City on the Move Institute and Associate Manager at Peugeot Media Production and on the board of 12 other companies. In the past he occupied the position of Chairman of Asm Auto Sud Marche SAS and CFO & Executive VP-Strategic Development at Peugeot SA Director at Banque PSA Finance SA, Chairman-Supervisory Board of Peugeot Finance International NV and Managing Director at Citroën BELUX SA (which are all subsidiaries of Peugeot SA). Jean-Baptiste Chasseloup de Chatillon received an undergraduate degree from Université Paris Dauphine and an undergraduate degree from the University of Lancaster.
Dominique Carouge Presently, Dominique Carouge is Executive VP & Head-Business Transformation at Sanofi. In the past he held the position of Chief Financial Officer at Hoechst Marion Roussel Australia Pty Ltd. He received an undergraduate degree from Reims Management School.
David G. Loew David G. Loew is Global Head-Vaccines at Sanofi. In his past career he held the position of Global Head-Product Strategy at Genentech, Inc.
Caroline Luscombe Caroline Luscombe holds the position of Executive Vice President-Human Resources at Sanofi. Ms. Luscombe previously was Head-Organization & Human Resources at LafargeHolcim Ltd., Executive Vice President-Human Resources at Amersham Plc and Head-Human Resources at Syngenta AG. Ms. Luscombe received an undergraduate degree from University College London.
Paul Hudson Paul Hudson is a businessperson who has been the head of 5 different companies. Currently, Mr. Hudson occupies the position of Chief Executive Officer & Director at Sanofi and Chairman at Novartis Pharma KK. In the past he held the position of Member-Executive Committee at Novartis AG and Chief Executive Officer at Novartis Pharmaceuticals Corp. (a subsidiary of Novartis AG) and President-AstraZeneca US & EVP-North America at AstraZeneca Plc President & Director at AstraZeneca KK and President for AstraZéneca Farmacéutica Spain SA (both are subsidiaries of AstraZeneca Plc). Paul Hudson received an undergraduate degree from Manchester Metropolitan University of.
Ameet Nathwani Currently, Ameet Nathwani holds the position of Chief Medical & Digital Officer at Sanofi. In the past he occupied the position of Global Head-Medical Affairs at Novartis Pharma AG and Head-Critical Care at Novartis Pharma AG.
Diane D. Souza Diane D. Souza is on the board of Amica Mutual Insurance Co., Sanofi, Farm Credit East, ACA and DBP Services of New York IPA, Inc. Mr. Souza previously occupied the position of Chief Executive Officer-Specialty Benefits at UnitedHealth Group, Inc. Chief Executive Officer of UnitedHealthcare Specialty Benefits LLC and COO-OptumHealth Specialty Benefits at OptumHealth, Inc. (both are subsidiaries of UnitedHealth Group, Inc.), Accountant of Pricewaterhouse LLP and CFO-Guaranteed Products Business at Aetna, Inc. He received an undergraduate degree from the University of Massachusetts.
Bill Sibold Bill Sibold is on the board of Biotechnology Innovation Organization and Executive Vice President-Sanofi Genzyme at Sanofi.
Marion Palme Marion Palme is on the board of Sanofi and Member of Industriegewerkschaft Bergbau Chemie Energie. In her past career Ms. Palme was Member of European Works Council. Ms. Palme received an undergraduate degree from Provadis School of International Management & Technology.
Christian Senectaire Christian Senectaire is on the board of Sanofi.
Nestle Frank Currently, Nestle Frank is Global Head-Immunology Therapeutic Research Area at Sanofi.
Christophe Babule Currently, Christophe Babule holds the position of Chief Financial Officer & Executive Vice President at L'Oréal SA. He is also on the board of Sanofi and L'Oréal USA, Inc. Mr. Babule received an undergraduate degree from École des Hautes Études Commerciales de Paris.
Alan Main Alan Main is Executive Vice President-Consumer Health Care at Sanofi. In his past career he occupied the position of Marketing Manager at Roche Enterprises Ltd. and Chairman-Marketing Council at Bayer HealthCare AG. He received an undergraduate degree from the University of Greenwich.
Claire Terrazas Presently, Claire Terrazas holds the position of Vice President-Corporate Legal Affairs at Sanofi.
Arnaud Delépine Arnaud Delépine is Investor Relations Officer at Sanofi.